Yongxia Cai1,2, Yanbo Shen3,4, Lili Gao5,6, Minmin Chen7,8, Min Xiao9, Zhongwei Huang10,11, Dongmei Zhang12,13. 1. Department of Emergency, Affiliated Hospital of Nantong University, Nantong, 226001, Jiangsu, People's Republic of China. yongxiacai@163.com. 2. Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Target, Nantong University, Nantong, 226001, Jiangsu, People's Republic of China. yongxiacai@163.com. 3. Department of Emergency, Affiliated Hospital of Nantong University, Nantong, 226001, Jiangsu, People's Republic of China. yanboshen123@163.com. 4. Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Target, Nantong University, Nantong, 226001, Jiangsu, People's Republic of China. yanboshen123@163.com. 5. Department of Emergency, Affiliated Hospital of Nantong University, Nantong, 226001, Jiangsu, People's Republic of China. liligao11@126.com. 6. Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Target, Nantong University, Nantong, 226001, Jiangsu, People's Republic of China. liligao11@126.com. 7. Department of Emergency, Affiliated Hospital of Nantong University, Nantong, 226001, Jiangsu, People's Republic of China. minminchen12@126.com. 8. Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Target, Nantong University, Nantong, 226001, Jiangsu, People's Republic of China. minminchen12@126.com. 9. National Glycoengineering Research Center, State Key Laboratory of Microbial Technology, Shandong University, Jinan, 250100, People's Republic of China. minxiao@sdu.edu.cn. 10. Department of Emergency, Affiliated Hospital of Nantong University, Nantong, 226001, Jiangsu, People's Republic of China. zhongweihuang88@163.com. 11. Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Target, Nantong University, Nantong, 226001, Jiangsu, People's Republic of China. zhongweihuang88@163.com. 12. Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Target, Nantong University, Nantong, 226001, Jiangsu, People's Republic of China. zdm@ntu.edu.cn. 13. Department of Pathogen Biology, Medical College, Nantong University, Nantong, 226001, Jiangsu, People's Republic of China. zdm@ntu.edu.cn.
Abstract
BACKGROUND: Activation of the transcription factor NF-κB and expression of pro-inflammatory mediators have been considered as major events of acute pancreatitis (AP). Karyopherin alpha 2 (KPNA2), a member of the importin α family, reportedly modulates p65 subcellular localization. AIM: This study aimed to investigate the expression and possible functions of KPNA2 in the AP cell and animal model, focusing on its association with NF-κB activation. METHODS: An AP cell model was established with the cerulein-stimulated AR42J and isolated rat pancreatic acinar cells. The AP rat model was induced by the intraperitoneal injection of cerulein. The secretion of TNF-α, IL-6, and LDH was detected by ELISA kits and the production of NO using nitric oxide kit. Expression of KPNA2 was measured by RT-PCR and Western blot. Expression levels of IKKα, phosphorylation of p65, and total p65 were detected by Western blot. Co-localization of KPNA2 with p65 was observed by immunofluorescence assay. To determine the biological functions of KPNA2 in cerulein-induced inflammatory response, RNA interference was employed to knockdown KPNA2 expression in AR42J and isolated pancreatic acini cells. RESULTS: Cerulein stimulated KPNA2 expression and IL-6, TNF-α, NO, and LDH production in rat pancreatic acinar cells. Cerulein triggered the phosphorylation and nuclear translocation of NF-κB p65 subunit, indicating the NF-κB activation. The co-localization and nuclear accumulation of KPNA2 and p65 were detected in cerulein-treated cells. Knocking down KPNA2 hindered cerulein-induced nuclear transportation of p65 and alleviated the subsequent inflammatory response in rat pancreatic acinar cells. Additionally, KPNA2 expression was significantly up-regulated in cerulein-induced AP rat model. CONCLUSIONS: KPNA2-facilitated p65 nuclear translocation promotes NF-κB activation and inflammation in acute pancreatitis.
BACKGROUND: Activation of the transcription factor NF-κB and expression of pro-inflammatory mediators have been considered as major events of acute pancreatitis (AP). Karyopherin alpha 2 (KPNA2), a member of the importin α family, reportedly modulates p65 subcellular localization. AIM: This study aimed to investigate the expression and possible functions of KPNA2 in the AP cell and animal model, focusing on its association with NF-κB activation. METHODS: An AP cell model was established with the cerulein-stimulated AR42J and isolated ratpancreatic acinar cells. The AP rat model was induced by the intraperitoneal injection of cerulein. The secretion of TNF-α, IL-6, and LDH was detected by ELISA kits and the production of NO using nitric oxide kit. Expression of KPNA2 was measured by RT-PCR and Western blot. Expression levels of IKKα, phosphorylation of p65, and total p65 were detected by Western blot. Co-localization of KPNA2 with p65 was observed by immunofluorescence assay. To determine the biological functions of KPNA2 in cerulein-induced inflammatory response, RNA interference was employed to knockdown KPNA2 expression in AR42J and isolated pancreatic acini cells. RESULTS:Cerulein stimulated KPNA2 expression and IL-6, TNF-α, NO, and LDH production in ratpancreatic acinar cells. Cerulein triggered the phosphorylation and nuclear translocation of NF-κB p65 subunit, indicating the NF-κB activation. The co-localization and nuclear accumulation of KPNA2 and p65 were detected in cerulein-treated cells. Knocking down KPNA2 hindered cerulein-induced nuclear transportation of p65 and alleviated the subsequent inflammatory response in ratpancreatic acinar cells. Additionally, KPNA2 expression was significantly up-regulated in cerulein-induced AP rat model. CONCLUSIONS:KPNA2-facilitated p65 nuclear translocation promotes NF-κB activation and inflammation in acute pancreatitis.
Authors: Matthias Sendler; Annegret Dummer; Frank U Weiss; Burkhard Krüger; Thomas Wartmann; Karin Scharffetter-Kochanek; Nico van Rooijen; Sudarshan Ravi Malla; Ali Aghdassi; Walter Halangk; Markus M Lerch; Julia Mayerle Journal: Gut Date: 2012-04-05 Impact factor: 23.059
Authors: Allison Lange; Ryan E Mills; Christopher J Lange; Murray Stewart; Scott E Devine; Anita H Corbett Journal: J Biol Chem Date: 2006-12-14 Impact factor: 5.157
Authors: María Micaela Molina-Navarro; Juan Carlos Triviño; Luis Martínez-Dolz; Francisca Lago; Jose Ramón González-Juanatey; Manuel Portolés; Miguel Rivera Journal: PLoS One Date: 2014-08-19 Impact factor: 3.240
Authors: Marcus Hollenbach; Sebastian Sonnenberg; Ines Sommerer; Jana Lorenz; Albrecht Hoffmeister Journal: PLoS One Date: 2021-01-25 Impact factor: 3.240